Hyattsville, Maryland Clinical Trials

A listing of Hyattsville, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 135 clinical trials
Long Term Follow-Up of Subjects Exposed to GSK3377794

This is a non-therapeutic, multi-center, long-term follow-up (LTFU) study of subjects who have, during the interventional study, received GSK3377794 generated by a process that utilizes lentiviral vectors. Subjects enrolled in the interventional studies who complete the interventional study or who withdraw from the interventional study will enter this LTFU study …

GSK Investigational Site
 (9.4 away) Contact site
  • 0 views
  • 30 Jul, 2020
  • +12 other locations
First in Human Dose Escalation of M3258 as a Single Agent and Expansion Study of M3258 in Combination With Dexamethasone

The purpose of this study is to determine the safety, tolerability, pharmacokinetics, pharmacodynamics and early efficacy signs of M3258 as a single agent and co-administered with dexamethasone in participants with Relapsed Refractory Multiple Myeloma (RRMM).

dexamethasone
carfilzomib
refractory multiple myeloma
measurable disease
bortezomib
Georgetown University Medical Center- Research Parent
 (7.9 away) Contact site
  • 10 views
  • 11 Nov, 2020
  • +5 other locations
Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma

Background Glioblastoma is a type of brain cancer. Treatments include radiation, chemotherapy, and surgery. But survival rates are poor. Researchers think that the drug selinexor, when combined with chemotherapy and radiation, might help. Objective To learn the highest dose of selinexor that people with brain cancer can tolerate when given …

therapeutic agent
platelet count
ct scan
cancer
neutrophil count
National Institutes of Health Clinical Center
 (9.7 away) Contact site
  • 43 views
  • 04 Dec, 2020
  • 1 location
Bintrafusp Alfa (M7824) and NHS-IL12 (M9241) Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies

Background Genitourinary cancers are some of the most common types of cancer. They are lethal when they spread. The drug M7824 blocks the paths that cancer cells use to stop the immune system from fighting cancer. The drug M9241 triggers the immune system to fight cancer. Researchers want to learn …

entecavir
metastasis
metastatic cancer
cancer
adefovir
National Institutes of Health Clinical Center
 (9.4 away) Contact site
  • 0 views
  • 14 Jan, 2021
  • 1 location
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Background Metastasis is the spread of cancer from one organ to a nonadjacent organ. It causes 90% of cancer deaths. No treatment specifically prevents or reduces metastasis. Researchers hope a new drug can help. It stops cancer cells from growing and spreading further and possibly shrink cancer lesions in distant …

x-rays
metastasis
ct scan
platelet count
cancer
National Institutes of Health Clinical Center
 (9.4 away) Contact site
  • 0 views
  • 19 Dec, 2020
  • 1 location